- 4.0Impact Factor
- 6.0CiteScore
- 27 daysTime to First Decision
International Journal of Neonatal Screening, Volume 11, Issue 4
2025 December - 33 articles
Cover Story: Newborn screening (NBS) has been a cornerstone of public health since the 1960s, saving thousands of children from severe disability or early death by detecting disorders early. Traditionally, NBS relies on biochemical markers, but many treatable rare diseases lack measurable biomarkers and remain unscreened. Genomic technologies offer a way to expand NBS beyond biochemical limitations. The BabyDetect project aimed to validate a targeted next-generation sequencing workflow for NBS, focusing on treatable, early-onset conditions. BabyDetect showed that genomic NBS can reliably detect pathogenic variants in diseases not covered by biochemical screening. With automation, quality control, and variant interpretation, genomic NBS is poised to complement and expand existing programs, addressing critical gaps in early detection and treatment. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

